FR-229934

MS-28637 | 99G2WZ2U4V | 3-[(3,4-dichlorophenyl)methyl]-2-methyl-N-pentylsulfonylbenzimidazole-5-carboxamide | FR-229934 | Q27272206 | 1H-Benzimidazole-6-carboxamide, 1-((3,4-dichlorophenyl)methyl)-2-methyl-N-(pentylsulfonyl)- | AKOS040751864 | HY-105686 |

FR-229934

F651291-5mg

5mg

≥98%

-20°C储存

超低温冰袋运输

FR-229934 is a PDE V inhibitor extracted from patent WO2019130052A1. FR-229934 can be used for the research of pulmonary arterial hypertension and erectile dysfunction Form:Solid IC50& Target:PDE V

FR-229934 是一种 PDE V 抑制剂，摘自专利 WO2019130052A1。FR-229934 可用于肺动脉高压和勃起功能障碍的研究。

799841-02-4

C21H23Cl2N3O3S

468.40 g/mol

11259905

CCCCCS(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(N2CC3=CC(=C(C=C3)Cl)Cl)C

3-[(3,4-dichlorophenyl)methyl]-2-methyl-N-pentylsulfonylbenzimidazole-5-carboxamide

1S/C21H23Cl2N3O3S/c1-3-4-5-10-30(28,29)25-21(27)16-7-9-19-20(12-16)26(14(2)24-19)13-15-6-8-17(22)18(23)11-15/h6-9,11-12H,3-5,10,13H2,1-2H3,(H,25,27)

QLXVZAXTUBLQJW-UHFFFAOYSA-N

CCCCCS(=O)(=O)NC(=O)C1=CC2=C(C=C1)N=C(N2CC3=CC(=C(C=C3)Cl)Cl)C

11259905

799841-02-4,405551-89-5

DMSO : 100 mg/mL (213.49 mM; Need ultrasonic)

1

4

8

467.084 Da

467.084 Da

89.400 Ų

30

0

687.000

0

1

5.300